Abstract:Background: Iron deficiency is a highly prevalent micronutrient abnormality and the most common cause of anemia globally, worsening the burden of adverse pregnancy and child outcomes. Objective: We sought to evaluate the response of hematologic biomarkers to iron supplementation and to examine the predictors of the response to iron supplementation among iron-deficient pregnant women. Methods: We identified 600 iron-deficient (serum ferritin ≤12 μg/L) pregnant women, aged 18-45 y, presenting to 2 antenatal clinics in Dar es Salaam, Tanzania using rapid ferritin screening tests, and prospectively followed them through delivery and postpartum. All women received 60 mg Fe and 0.25 mg folate daily from enrollment until delivery. Proportions meeting the thresholds representing deficient hematologic status including hemoglobin <110 g/L, ferritin ≤12 μg/L, serum soluble transferrin receptor (sTfR) >4.4 mg/L, zinc protoporphyrin (ZPP) >70 mmol/L, or hepcidin ≤13.3 μg/L at baseline and delivery were assessed. The prospective change in biomarker concentration and the influence of baseline hematologic status on the change in biomarker concentrations were assessed. Regression models were estimated to assess the relation of change in biomarker concentrations and pregnancy outcomes. Results: There was significant improvement in maternal biomarker concentrations between baseline and delivery, with increases in the concentrations of hemoglobin (mean difference: 15.2 g/L; 95% CI: 13.2, 17.2 g/L), serum ferritin (51.6 μg/L; 95% CI: 49.5, 58.8 μg/L), and serum hepcidin (14.0 μg/L; 95% CI: 12.4, 15.6 μg/L) and decreases in sTfR (-1.7 mg/L; 95% CI: -2.0, -1.3 mg/L) and ZPP (-17.8 mmol/L; 95% CI: -32.1, 3.5 mmol/L). The proportions of participants with low hemoglobin, ferritin, and hepcidin were 73%, 93%, and 99%, respectively, at baseline and 34%, 12%, and 46%, respectively, at delivery. The improvements in biomarker concentrations were significantly greater among participants with poor hematologic status at baseline - up to 12.1 g/L and 14.5 μg/L for hemoglobin and ferritin concentrations, respectively. For every 10-g/L increase in hemoglobin concentration, there was a 24% reduced risk of perinatal mortality (RR = 0.76; 95% CI: 0.59, 0.99) and a 23% reduced risk of early infant mortality (RR = 0.77; 95% CI: 0.60, 0.99). The risk of anemia at delivery despite supplementation was predicted by baseline anemia (RR = 2.11; 95% CI: 1.39, 3.18) and improvements in ferritin concentration were more likely to be observed in participants who took iron supplements for up to 90 d (RR = 1.41; 95% CI: 1.13, 1.76). Conclusion: Iron supplementation decreases the risk of maternal anemia and increases the likelihood of infant survival among iron-deficient Tanzanian pregnant women. Interventions to promote increased duration and adherence to iron supplements may also provide greater health benefits.

A Study on the Cytokine IL-2 and IL-6 Production in PBMC of Pregnant Women with Iron Deficiency

A study on proliferation of lymphocytes and cytokine production of TNF-α and IL-10 of pregnant women under dif-ferent iron concentrations

Study on the changes of RBC, Hct, and Ret levels in patients with anemia during pregnancy and clinical treatment

Study of the hepcidin level in pregnant women with and without anemia

Increased Serum Levels of Neopterin and Soluble Interleukin-2 Receptor in Intrahepatic Cholestasis of Pregnancy.

Circulating Innate Lymphoid Cells Exhibit Distinctive Distribution During Normal Pregnancy

Iron Supplementation Affects Hematologic Biomarker Concentrations and Pregnancy Outcomes among Iron-Deficient Tanzanian Women

Iron parameters in pregnant women with beta-thalassaemia minor combined with iron deficiency anaemia compared to pregnant women with iron deficiency anaemia alone demonstrate the safety of iron supplementation in beta-thalassaemia minor during pregnancy

Imbalance of Serum T Helper 1- and 2-Type Cytokines in Preeclampsia and Gestational Hypertension

Maternal Iron Status Is Dynamic Throughout Pregnancy and Might Predict Birth Outcomes in a Sex Dependent Manner: Results from the Alberta Pregnancy Outcomes and Nutrition (APrON) Cohort Study

Maternal Serum Ferritin Concentration is Positively Associated with Newborn Iron Stores in Women with Low Ferritin Status in Late Pregnancy, ,

Evaluation of neopterin,soluble interleukin-2 receptor and T-helper cell in intrahepatic cholestasis of pregnancy

Evaluation on effect of improved iron nutrition of pregnant women with intermittent iron supplementation

[Survey of Prevalence of Iron Deficiency and Iron Deficiency Anemia in Pregnant Women in Urban Areas of China].

Changes and significance of serum IL-2,IL-6 and IL-10 in patients with hypertensive disorder complicating pregnancy

Impact of Iron‐containing Micronutrient Supplementation on High Hemoglobin Concentration During Pregnancy

Iron-containing Micronutrient Supplementation of Chinese Women with No or Mild Anemia During Pregnancy Improved Iron Status but Did Not Affect Perinatal Anemia.

The change of Th1/Th2 cytokines produced by decidua mononuclearcells in patients with pregnancy induced hypertension

Maternal Overweight and Obesity During Pregnancy Are Associated with Neonatal, but Not Maternal, Hepcidin Concentrations

EFFECT OF VITAMIN A AND IRON SUPPLEMENTATION ON IRON STATUS DURING PREGNANCY

A epidemiological survey of iron depletion and iron deficiency anemia in pregnant women in shaanxi province